Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03317249
Other study ID # PRIST
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date October 6, 2017
Est. completion date October 6, 2020

Study information

Verified date January 2019
Source Cambridge University Hospitals NHS Foundation Trust
Contact Mark Belham
Phone 01223 349154
Email mark.belham@addenbrookes.nhs.uk
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

A feasibility study into the exploration of possible mechanisms underlying inappropriate sinus tachycardia (IST) syndrome in pregnancy.


Description:

This is a non-interventional, physiological study which will explore the feasibility of examining autonomic function and related haemodynamic variables in pregnant women with and without inappropriate sinus tachycardia, with the aim of providing scope for future research.

Sinus tachycardia (normal heart rhythm but fast heart rate) is common and usually related to an obvious cause (e.g. exercise such a running or cycling) and doesn't cause any untoward symptoms. In rare cases however, sinus tachycardia can occur without an obvious cause (i.e. it is inappropriate to the situation) and can cause distressing symptoms such as palpitations, dizziness and breathlessness at rest or with minimal exertion. This syndrome of inappropriate sinus tachycardia is poorly understood and can be difficult to manage; especially when the affected individual is pregnant. In order to understand the condition better and improve care pathways we aim to measure various features of the cardiovascular system in pregnant women with and without IST.


Recruitment information / eligibility

Status Recruiting
Enrollment 200
Est. completion date October 6, 2020
Est. primary completion date October 6, 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years to 45 Years
Eligibility Inclusion Criteria:

- Aged 18-45 years of age

- Able to give written informed consent and willing to participate

- The participant falls into one of the below categories:

i. Pregnant women with IST ii. Pregnant women without IST

Exclusion Criteria:

- Obesity (BMI > 29.9)

- Current or recent (within last 3 months) smoker

- Known medical condition likely to affect HRV (other than IST in relevant groups)

- Previous history of hypertensive disorders in pregnancy

- Lack of written informed consent

Study Design


Intervention

Diagnostic Test:
ECG
12-lead electrocardiogram
heart rate monitor
24-hour heart rate monitor used to calculate mean heart rate and heart rate variability
Autonomic Nervous System (ANS) Activity
Heart Rate Variability (HRV) and Baroreflex sensitivity (BRS): Resting and exercise HRV and BRS calculated from ECG, Dundee Step test and blood pressure measurements.
Haemodynamic variables
Cardiac output (CO), stroke volume (SV) and systematic vascular resistance (SVR) will be assessed and calculated using a non-invasive, inert gas re-breathing technique whereby expired gases will be sampled and analysed alongside and blood pressure measurements.
Other:
Echocardiogram
optional (for non-IST participants only)

Locations

Country Name City State
United Kingdom Addenbrookes Hospital Cambridge

Sponsors (1)

Lead Sponsor Collaborator
Cambridge University Hospitals NHS Foundation Trust

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary Feasibility of examining autonomic function and related haemodynamic variables in pregnant women with and without inappropriate sinus tachycardia Number of women in each group who agree to participate in the study Up to 3 years
Primary Assessment of autonomic function and related haemodynamic variables in pregnant women with and without inappropriate sinus tachycardia Heart rate variability (HRV) at rest using time and frequency domain (e.g. SDNN ms and LF and HF), combined to give absolute power in ms². Up to 3 years
Primary Assessment of autonomic function and related haemodynamic variables in pregnant women with and without inappropriate sinus tachycardia Baroreflex sensitivity (BRS) at rest calculated from the change in systolic pressure and change in R-R interval to give change in pressure per change in RR interval, measured in milliseconds (mmHg/ms) Up to 3 years
Secondary Assessment of ANS function in pregnant women with and without IST, at rest and during mild exercise Stroke volume in ml Up to 3 years
Secondary Assessment of ANS function in pregnant women with and without IST, at rest and during mild exercise Heart Rate Variability during mild exercise (3 minute step test) using time and frequency domain (e.g. SDNN ms and LF and HF), combined to give absolute power in ms². Up to 3 years
Secondary Assessment of ANS function in pregnant women with and without IST, at rest and during mild exercise Cardiac Output in litres/minute Up to 3 years
Secondary Assessment of ANS function in pregnant women with and without IST, at rest and during mild exercise Blood Pressure in mm/Hg Up to 3 years
See also
  Status Clinical Trial Phase
Completed NCT05017974 - Research on Improving Sleep During Pregnancy N/A
Completed NCT03284515 - Vaccination In Pregnancy Gene Signature: VIP Signature Study
Recruiting NCT05969795 - Comparison of Live Birth Rate in Natural Cycle Single Euploid FET Versus Without Luteal Phase Support Phase 1
Recruiting NCT06051201 - Innovation for Small-scale Experiments: ReceptIVFity Test N/A
Recruiting NCT04828382 - Prospective Study of Pregnancy in Women With Cystic Fibrosis
Enrolling by invitation NCT04527926 - STEPuP: Prenatal Provider Education and Training to Improve Medication-assisted Treatment Use During Pregnancy N/A
Recruiting NCT04278651 - Early Antenatal Support for Iron Deficiency Anemia Phase 4
Recruiting NCT04405700 - Measuring Adverse Pregnancy and Newborn Congenital Outcomes
Recruiting NCT06258902 - Odevixibat Pregnancy and Lactation Surveillance Program: A Study to Evaluate the Safety of Odevixibat During Pregnancy and/or Lactation
Completed NCT05487196 - Effectiveness of Clonidine, Dexmedetomidine, and Fentanyl Adjuncts for Labor Epidural Analgesia Phase 2
Completed NCT03750968 - Lutein & Zeaxanthin in Pregnancy - Carotenoid Supplementation During Pregnancy: Ocular and Systemic Effects Phase 2
Enrolling by invitation NCT06127277 - Next4You: A Fully Mobile Relationships Based Program for Youth in Foster Care N/A
Completed NCT05897697 - Assessing Women's Preferences for Postpartum Thromboprophylaxis: the Prefer-Postpartum Study
Recruiting NCT05899101 - The Impact of Opioid and Cannabis Exposure on Fetal Growth
Completed NCT05502510 - Assessing the Effectiveness and Efficacy of the MyHealthyPregnancy Application
Completed NCT04296396 - Opioid Prescription After Cesarean Trial Phase 3
Not yet recruiting NCT06069869 - Multiple Micronutrient Supplementation (MMS) Iron Dose Acceptability Crossover Trial Phase 3
Not yet recruiting NCT06069856 - Multiple Micronutrient Supplementation (MMS) IFA- Iron Dose Acceptability Crossover Trial Phase 3
Not yet recruiting NCT06079918 - Multiple Micronutrient Supplementation for Maternal Anemia Prevention in Tanzania Phase 3
Not yet recruiting NCT06163651 - Evaluating a One-Year Version of the Parent-Child Assistance Program N/A